Cargando…

Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS

OBJECTIVE: To determine the diagnostic and prognostic significance of neurofilament light chain (NfL), TAR DNA‐binding protein 43 (TDP‐43), and total tau (t‐tau) in cerebrospinal fluid (CSF) and plasma of patients with amyotrophic lateral sclerosis (ALS) and to investigate whether the combined use o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasai, Takashi, Kojima, Yuta, Ohmichi, Takuma, Tatebe, Harutsugu, Tsuji, Yukiko, Noto, Yu‐ichi, Kitani‐Morii, Fukiko, Shinomoto, Makiko, Allsop, David, Mizuno, Toshiki, Tokuda, Takahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917342/ https://www.ncbi.nlm.nih.gov/pubmed/31742901 http://dx.doi.org/10.1002/acn3.50943

Ejemplares similares

Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics
por: Kojima, Yuta, et al.
Publicado: (2021)

Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease
por: Shinomoto, Makiko, et al.
Publicado: (2021)

Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
por: Ohmichi, Takuma, et al.
Publicado: (2020)

Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson’s disease
por: Ohmichi, Takuma, et al.
Publicado: (2018)

Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients
por: Shinomoto, Makiko, et al.
Publicado: (2019)

Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson’s disease
por: Ohmichi, Takuma, et al.
Publicado: (2023)

Risk factors for neuropsychiatric symptoms in patients with Parkinson’s disease during COVID-19 pandemic in Japan
por: Kitani-Morii, Fukiko, et al.
Publicado: (2021)

Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy
por: Kasai, Takashi, et al.
Publicado: (2016)

Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference
por: Ishii, Ryotaro, et al.
Publicado: (2015)

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
por: Tatebe, Harutsugu, et al.
Publicado: (2017)

Increased levels of plasma total tau in adult Down syndrome
por: Kasai, Takashi, et al.
Publicado: (2017)

Rate of Changes in CMT Neuropathy and Examination Scores in Japanese Adult CMT1A Patients
por: Kitani-Morii, Fukiko, et al.
Publicado: (2020)

Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus
por: Margraf, Nils G., et al.
Publicado: (2023)

Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer’s disease
por: Kasai, Takashi, et al.
Publicado: (2017)

Differential Expression of Alpha-Synuclein in Hippocampal Neurons
por: Taguchi, Katsutoshi, et al.
Publicado: (2014)

p62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions
por: Watanabe, Yoshihisa, et al.
Publicado: (2012)

Recent Advances in Drosophila Models of Charcot-Marie-Tooth Disease
por: Kitani-Morii, Fukiko, et al.
Publicado: (2020)

Increased CSF NFL in Non-demented Parkinson’s Disease Subjects Reflects Early White Matter Damage
por: Papuć, Ewa, et al.
Publicado: (2020)

Drosophila as a Model for Microbiota Studies of Neurodegeneration
por: Kitani-Morii, Fukiko, et al.
Publicado: (2021)

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
por: Ren, Yuting, et al.
Publicado: (2021)

Diagnostic Value of Muscle [(11)C] PIB-PET in Inclusion Body Myositis
por: Noto, Yu-ichi, et al.
Publicado: (2020)

Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF
por: Audrain, Mickael, et al.
Publicado: (2023)

Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community‐based sample of 70‐year‐olds
por: Dittrich, Anna, et al.
Publicado: (2022)

Effect of Estimated Blood Volume and Body Mass Index on GFAP and NfL Levels in the Serum and CSF of Patients With Multiple Sclerosis
por: Yalachkov, Yavor, et al.
Publicado: (2022)

Value of CSF-Cl, CSF-GS, CSF-MALB, and CSF-ADA in Differential Diagnosis of Secondary Hydrocephalus
por: Huang, Junzhang, et al.
Publicado: (2022)

Retracted: Value of CSF-Cl, CSF-GS, CSF-MALB, and CSF-ADA in Differential Diagnosis of Secondary Hydrocephalus
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

IMMU-02. CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL NEUROTOXICITY CORRELATES WITH PRETREATMENT AND ACUTE CSF NEUROFILAMENT LIGHT CHAIN (NFL) LEVELS
por: Gust, Juliane, et al.
Publicado: (2020)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

TDP-43 CSF Concentrations Increase Exponentially with Age in Metropolitan Mexico City Young Urbanites Highly Exposed to PM(2.5) and Ultrafine Particles and Historically Showing Alzheimer and Parkinson’s Hallmarks. Brain TDP-43 Pathology in MMC Residents Is Associated with High Cisternal CSF TDP-43 Concentrations
por: Calderón-Garcidueñas, Lilian, et al.
Publicado: (2022)

In-depth Characterization of the Cerebrospinal Fluid (CSF) Proteome Displayed Through the CSF Proteome Resource (CSF-PR)
por: Guldbrandsen, Astrid, et al.
Publicado: (2014)

A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014)

CSF protein variations correlates with CSF oscillations in hydrocephalus patients
por: Balédent, Olivier, et al.
Publicado: (2015)

Marchiafava-Bignami disease with hyperintensity on late diffusion-weighted imaging
por: Iwai, Takayasu, et al.
Publicado: (2014)

Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure
por: Ding, Xuebing, et al.
Publicado: (2015)

GM-CSF Treated F4/80(+) BMCs Improve Murine Hind Limb Ischemia Similar to M-CSF Differentiated Macrophages
por: Kuwahara, Go, et al.
Publicado: (2014)

CSF User Guide
por: Boissat, Christian, et al.
Publicado: (1993)

Cellular Diagnostics of CSF
por: Urbanits, Sabine
Publicado: (2004)

GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019)

CSF-to-dura gateways
por: Thomas, Jean-Leon, et al.
Publicado: (2022)

Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease
por: Mizutani, Yasuaki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ed0ehfuuh86hipigc51eln6hcb